Meet the investigator: Tanios S. Bekaii-Saab
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Tanios S. Bekaii-Saab, M.D., a medical oncologist at Mayo Clinic in Phoenix/Scottsdale, Arizona, explains how his research interests grew out of a desire to improve treatment options for his patients.
This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.
Related Posts

Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies.

Study results show people with grade 4 glioblastoma may benefit from a new approach to treatment that uses advanced imaging and proton beam therapy.

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.